N-13-[(10S,13S)-9,12-DIOXO-10-(2-BUTYL)-2-OXA-8,11-DIAZABICYCLO [13.2.2] NONADECA-15,17,18-TRIENE] (2R)-BENZYL-(4S)-HYDROXY-5-AMINOPENTANOIC (1R)-HYDROXY-(2S)-INDANEAMIDE

(2R,4S)-2-Benzyl-5-{[(10S,13S)-10-[(2S)-2-butanyl]-9,12-dioxo-2-oxa-8,11-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-13-yl]amino}-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamid

(2R,4S)-2-Benzyl-5-{[(10S,13S)-10-[(2S)-2-butanyl]-9,12-dioxo-2-oxa-8,11-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-13-yl]amino}-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamid e

(2R,4S)-2-Benzyl-5-{[(10S,13S)-10-[(2S)-2-butanyl]-9,12-dioxo-2-oxa-8,11-diazabicyclo[13.2.2]nonadéca-1(17),15,18-trién-13-yl]amino}-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-indén-1-yl]pentanamid e

N-13-[(10S,13S)-9,12-DIOXO-10-(2-BUTYL)-2-OXA-8,11-DIAZABICYCLO [13.2.2] NONADECA-15,17,18-TRIENE] (2R)-BENZYL-(4S)-HYDROXY-5-AMINOPENTANOIC (1R)-HYDROXY-(2S)-INDANEAMIDE

MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 8